ARTICLE SUMMARY:
Sherlock and binx are teaming up to develop a rapid molecular test for SARS-CoV-2 that can be used in point-of-care settings to produce results in approximately 20 minutes or less.
While Sherlock Biosciences and binx health inc. are not the first to throw their hats into the high-stakes, frustrating, rapid testing ring, they certainly come to the table with credible track records, top management teams, and a few FDA wins.
